The city of Glendale, California, currently has 1 active clinical trials seeking participants for Parkinson's Disease research studies.
A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants With Parkinson's Disease
Recruiting
The goal of this study is to test KM-819 in halting or slowing the progression of Parkinson's disease. The study evaluates the safety and tolerability of multiple ascending doses of KM-819 in healthy older adults and participants with Parkinson's disease.
Gender:
All
Ages:
40 years and above
Trial Updated:
02/14/2024
Locations: Parexel Early Phase Clinical Unit, Glendale, California
Conditions: Parkinson Disease